关注
Meixiang Huang
Meixiang Huang
Post-doc Fellow of Johns Hopkins Drug Discovery, Neurology, Johns Hopkins School of Medicine, Brain
在 jh.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Molecular signatures of neuroinflammation induced by αsynuclein aggregates in microglial cells
S Sarkar, EB Dammer, E Malovic, AL Olsen, SA Raza, T Gao, H Xiao, ...
Frontiers in immunology 11, 33, 2020
782020
Network analysis of the progranulin-deficient mouse brain proteome reveals pathogenic mechanisms shared in human frontotemporal dementia caused by GRN mutations
M Huang, E Modeste, E Dammer, P Merino, G Taylor, DM Duong, Q Deng, ...
Acta neuropathologica communications 8, 1-25, 2020
752020
Deletion of neuronal CuZnSOD accelerates age-associated muscle mitochondria and calcium handling dysfunction that is independent of denervation and precedes sarcopenia
Y Su, DR Claflin, M Huang, CS Davis, PCD Macpherson, A Richardson, ...
International Journal of Molecular Sciences 22 (19), 10735, 2021
152021
Inhibiting tau-induced elevated nSMase2 activity and ceramides is therapeutic in an Alzheimer’s disease mouse model
C Tallon, BJ Bell, MM Malvankar, P Deme, C Nogueras-Ortiz, E Eren, ...
Translational Neurodegeneration 12 (1), 56, 2023
82023
Microglial-Targeted nSMase2 Inhibitor Fails to Reduce Tau Propagation in PS19 Mice
M Huang, C Tallon, X Zhu, KDJ Huizar, S Picciolini, AG Thomas, L Tenora, ...
Pharmaceutics 15 (9), 2364, 2023
22023
GCPII Inhibition Promotes Remyelination after Peripheral Nerve Injury in Aged Mice
Y Su, M Huang, AG Thomas, J Maragakis, KDJ Huizar, Y Zheng, Y Wu, ...
International journal of molecular sciences 25 (13), 6893, 2024
12024
Microglial‐targeted nSMase2 inhibitor fails to reduce tau spread in the animal model of Alzheimer’s disease
M Huang, C Tallon, X Zhu, K Huizar, S Piccirillo, AG Thomas, L Tenora, ...
Alzheimer's & Dementia 20, e091930, 2024
2024
Dectin-1 as a therapeutic target for inflammatory bowel disease
Y Li, M Huang, S Cardinale, Y Su, DE Peters, BS Slusher, X Zhu
Advances in pharmacology (San Diego, Calif.) 101, 237, 2024
2024
Drug Development LPR: Drug discovery for Alzheimer's disease and related dementias
JL Dage, M Huang
Alzheimer's Association International Conference, 2024
2024
GCPII Inhibition in Macrophages Delays Age-related Muscle Atrophy in Mice
Y Su, C Tallon, A Thomas, K Huizar, M Huang, L Tenora, W Liyanage, ...
Physiology 39 (S1), 2379, 2024
2024
Neutral sphingomyelinase 2: A promising drug target for CNS disease
M Huang, M Stremlau, J Zavras, C Zivko, AG Thomas, P Pietri, ...
Advances in Pharmacology, 2024
2024
Inhibition of EV biogenesis reduces tau propagation in Alzheimer’s Disease mouse models
M Huang, C Tallon, BJ Bell, D Kapogiannis, NJ Haughey, R Rais, ...
Alzheimer's & Dementia 19, e078341, 2023
2023
Preclinical therapeutic targets and early phase studies
TD Prevot, M Huang
Alzheimer's Association International Conference, 2023
2023
Network analysis of the brain proteome of GRN knockout mice reveals pathogenic mechanisms shared in human frontotemporal dementia caused by GRN mutations: Developing topics
T Kukar, M Huang, ES Modeste, EB Dammer, CJ Holler, Q Deng, ...
Alzheimer's & Dementia 16, e047569, 2020
2020
Network Analysis of the Brain Proteome of Grn Knockout Mice Reveals Pathogenic Mechanisms Shared in Human Frontotemporal dementia caused by GRN mutations.
M Huang
The FASEB Journal 34 (S1), 1-1, 2020
2020
系统目前无法执行此操作,请稍后再试。
文章 1–15